Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply.
Tse WC, Djordjevic F, Borja V, Picco L, Lam T, Olsen A, Larney S, Dietze P, Nielsen S
Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study).
O'Keefe D, Gunn J, Ryan K, Djordjevic F, Kerr P, Gold J, Elsum I, Layton C, Chan K, Dietze P, Higgs P, Doyle J, Stoové MA, Hellard M, Pedrana AE
Health service utilisation and access for people who inject drugs during COVID-19.
Efunnuga H, Higgs P, Walker S, O'Keefe D
COVID-19
Increasing hepatitis C testing and linkage to care: Results of a testing campaign with incentives at primary care clinics in Melbourne, Australia.
Chan K, Elsum I, Gold J, Layton C, Accadia L, Bryant M, Gunn J, Djordjevic F, Purcell I, Dicka J, Forrest M, Crawford S, Hellard M, Pedrana A, Eliminate Hepatitis C Partnership
Ketamine Use Among People Who Regularly Use Ecstasy and Other Illicit Stimulants in Australia: Trends and Characteristics of Use, 2009-2019.
Stewart AC, Peacock A, Djordjevic F, Cossar R, Salom C, Lenton S, Dietze P
The feasibility of a drug consumption room in the Australian Capital Territory.
Kirwan A, Winter R, Gunn J, Djordjevic F, Curtis M, Gough C, Dietze PM
- 1
- 2